Tuberculosis Research in Rio

Nurses assistant Janaina Lisboa, right, takes a blood sample from tuberculosis patient Francisco Eusebio de A. Filho at the Hospital Universitrio Clementino Fraga Filho in Rio de Janeiro, Brazil, May 17, 2006. The TB program at the hospital is being assessed by a team from the TB alliance. The mission of the not-for-profit company is to ensure the development of faster and affordable new cure for tuberculosis. ÊWith no laboratories or clinical sites of their own, it works through strategic partnerships with research institutions and pharmaceutical companies from the discovery phase through clinical trials. The team is in Rio to see if the hospital fits into their plans. The TB Alliance selects the best drug candidates, coordinates between partners, manages projects, and facilitates regulatory approval. (Australfoto/Douglas Engle)

1 / 18

Nurses assistant Janaina Lisboa, right, takes a blood sample from tuberculosis patient Francisco Eusebio de A. Filho at the Hospital Universitrio Clementino Fraga Filho in Rio de Janeiro, Brazil, May 17, 2006. The TB program at the hospital is being assessed by a team from the TB alliance. The mission of the not-for-profit company is to ensure the development of faster and affordable new cure for tuberculosis. ÊWith no laboratories or clinical sites of their own, it works through strategic partnerships with research institutions and pharmaceutical companies from the discovery phase through clinical trials. The team is in Rio to see if the hospital fits into their plans. The TB Alliance selects the best drug candidates, coordinates between partners, manages projects, and facilitates regulatory approval. (Australfoto/Douglas Engle)

brasil brazil contagious drug health infectious pharmaceutical research tuberculosis